Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 38Breast Neoplasms 31Lung Neoplasms 25Colorectal Neoplasms 15Prostatic Neoplasms 13Pancreatic Neoplasms 11Ovarian Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Head and Neck Neoplasms 9Sarcoma 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Uterine Cervical Neoplasms 7Glioma 7Esophageal Neoplasms 7Melanoma 6Lymphoma 6Endometrial Neoplasms 6Neoplastic Cells, Circulating 5Multiple Myeloma 5Brain Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Neoplasm, Residual 4Gastrointestinal Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Renal Cell 4Adenocarcinoma 4Thrombosis 3Rectal Neoplasms 3

Interventions

pembrolizumab 2darolutamide 2relatlimab 1olaparib 1gedatolisib 1enfortumab vedotin 1Surveys and Questionnaires 1Radiation Dose Hypofractionation 1Pluvicto 1Nivolumab 1Mitomycin 1Gemcitabine 1Fluorouracil 1Cisplatin 1CP protocol 1Blood Specimen Collection 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Male Urogenital Diseases × Blood Specimen Collection × Clear all
NCT06659926 2025-07-08

The Radium-select Study

The Netherlands Cancer Institute

Phase NA Recruiting
60 enrolled

Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡